I am a
Home I AM A Search Login

Papers of the Week

2019 Sep

Int Immunopharmacol


A large scale meta analysis identifies common adverse events with checkpoint inhibitors vs chemotherapy in melanoma patients.


Zhang R, Li X, You Z, Jiang L, Weng Y, Shi Q, DU L, Yan S
Int Immunopharmacol. 2019 Sep; 74:105691.
PMID: 31252248.


A meta-analysis was performed to assess the risk of common adverse events in melanoma patients treated with checkpoint inhibitors.